0001209191-23-050674.txt : 20230927 0001209191-23-050674.hdr.sgml : 20230927 20230927171348 ACCESSION NUMBER: 0001209191-23-050674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230926 FILED AS OF DATE: 20230927 DATE AS OF CHANGE: 20230927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Himawan Jeff CENTRAL INDEX KEY: 0001342821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 231285449 MAIL ADDRESS: STREET 1: ESSEX WOODLANDS HEALTH VENTURES STREET 2: 435 TASSO STREET, SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-26 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001342821 Himawan Jeff C/O HORIZON THERAPEUTICS PLC, 70 ST. STEPHEN?S GREEN DUBLIN L2 D02 E2X4 IRELAND 1 0 0 0 0 Ordinary Shares 2023-09-26 4 M 0 32161 13.87 A 44546 D Ordinary Shares 7873 I By Pt Rd Foundation Ordinary Shares 36609 I By Trust Stock Option (Right to Buy) 13.87 2023-09-26 4 M 0 32161 0.00 D 2028-05-02 Ordinary Shares 32161 0 D 10,264 shares previously reported as held indirectly by Trust are now held directly. The stock option is fully vested. /s/ Meghanne Downes, Attorney-in-Fact 2023-09-27